Nischarin agonist rilmenidine shows antimetastatic potential in pancreatic ductal adenocarcinoma

Kristina Živić(Oncology Institute of Vojvodina), Jelena Grahovac(Oncology Institute of Vojvodina)
bioRxiv (Cold Spring Harbor Laboratory)
October 27, 2025
Cited by 0


Related Papers